Dido Vassilacopoulou Selected Research

Carboxy-Lyases

2/2021	Next-generation sequencing reveals alternative L-DOPA decarboxylase (DDC) splice variants bearing novel exons, in human hepatocellular and lung cancer cells.
1/2021	Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
11/2020	Revised Exon Structure of l-DOPA Decarboxylase (DDC) Reveals Novel Splice Variants Associated with Colorectal Cancer Progression.
11/2019	Identification of novel alternative splice variants of the human L-DOPA decarboxylase (DDC) gene in human cancer cells, using high-throughput sequencing approaches.
1/2019	Emerging Role of l-Dopa Decarboxylase in Flaviviridae Virus Infections.
1/2018	Evidence for L-Dopa Decarboxylase Involvement in Cancer Cell Cytotoxicity Induced by Docetaxel and Mitoxantrone.
2/2011	L-Dopa decarboxylase expression profile in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dido Vassilacopoulou Research Topics

Disease

4	Neoplasms (Cancer) 11/2019 - 02/2011
3	Virus Diseases (Viral Diseases) 10/2021 - 01/2019
2	Hypoxia (Hypoxemia) 01/2021 - 12/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2018
2	Neuroblastoma 09/2019 - 05/2019
2	Adenocarcinoma 01/2018 - 01/2018
1	Lung Neoplasms (Lung Cancer) 02/2021
1	COVID-19 01/2021
1	Infections 01/2021
1	Epilepsy (Aura) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Drug Resistant Epilepsy 01/2020
1	Neoplasm Metastasis (Metastasis) 05/2019
1	Carcinogenesis 05/2019
1	Hepatocellular Carcinoma (Hepatoma) 05/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 02/2021 - 02/2011
7	Carboxy-LyasesIBA 02/2021 - 02/2011
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
1	CatecholaminesIBA 10/2021
1	EnzymesIBA 10/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	InterferonsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	RNA IsoformsIBA 11/2019
1	Amyloid (Amyloid Fibrils)IBA 09/2019
1	Proteins (Proteins, Gene)FDA Link 09/2019
1	alpha-SynucleinIBA 09/2019
1	AntibodiesIBA 05/2019
1	Biomarkers (Surrogate Marker)IBA 05/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2019
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Oxygen (Dioxygen)IBA 12/2018
1	AndrogensIBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018

Therapy/Procedure

1	Precision Medicine 01/2020
1	Drug Therapy (Chemotherapy) 01/2018